Clarity Pharmaceuticals (ASX: CU6) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Clarity Pharmaceuticals Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Clarity Pharmaceuticals (ASX: CU6)
Latest News
Broker Notes
Bell Potter says this ASX 200 stock can rise 100%+
Share Market News
5 things to watch on the ASX 200 on Wednesday
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Market News
Why Clarity, Coronado Global, Iperionx, and Lynas shares are roaring higher today
Healthcare Shares
Which ASX 200 stock is jumping 11% on big news?
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today
Healthcare Shares
Guess which ASX 200 stock is jumping 10% on big news
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Breville, Clarity, EOS, and TechnologyOne shares are racing higher today
Healthcare Shares
Trump executive order to hit these 3 ASX pharmaceutical stocks
CU6 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Clarity Pharmaceuticals
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.